Please use this identifier to cite or link to this item: https://hdl.handle.net/10316/113822
DC FieldValueLanguage
dc.contributor.authorSantos, Érica Mendes Dos-
dc.contributor.authorAtaide, Janaína Artem-
dc.contributor.authorCoco, Julia Cedran-
dc.contributor.authorFava, Ana Laura Masquetti-
dc.contributor.authorSilvério, Luiza Aparecida Luna-
dc.contributor.authorSueiro, Ana Claudia-
dc.contributor.authorSilva, Jéssica Ribeiro Alves-
dc.contributor.authorLopes, André Moreni-
dc.contributor.authorPaiva-Santos, Ana Cláudia-
dc.contributor.authorMazzola, Priscila Gava-
dc.date.accessioned2024-03-05T13:07:23Z-
dc.date.available2024-03-05T13:07:23Z-
dc.date.issued2023-02-16-
dc.identifier.issn1420-3049pt
dc.identifier.urihttps://hdl.handle.net/10316/113822-
dc.description.abstractMany plants are used by the population through popular knowledge passed from generation to generation for the treatment of various diseases. However, there is not always any scientific content supporting these uses, which is very important for safety. One of these plants is the fruit of the Spondias genus, which during its processing generates various residues that are discarded, but which also have pharmacological properties. The focus of this review is to survey the pharmacological activities that Spondias genus shows, as well as which part of the plant is used, since there is a lot of richness in its by-products, such as leaf, bark, resin, seed, and peel, which are discarded and could be reused. The main activities of this genus are antioxidant, anti-inflammatory, antidiabetic, antifungal, and antiviral, among others. These properties indicate that this genus could be used in the treatment of several diseases, but there are still not many products available on the market that use this genus as an active ingredient.pt
dc.language.isoengpt
dc.publisherMDPIpt
dc.relationThis research was funded by Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP), grant numbers 2020/11333-4; 2018/07707-6; 2018/06475-4; 2021/00319-3; 2017/10789-1; and 2018/10799-0, and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior—Brasil (CAPES) (Finance Code 001)pt
dc.rightsopenAccesspt
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/pt
dc.subjectSpondiaspt
dc.subjectantioxidantpt
dc.subjectanti-inflammatorypt
dc.subjectantibacterialpt
dc.subjectbiological activitypt
dc.subjectbioactive compoundspt
dc.subject.meshEthnopharmacologypt
dc.subject.meshPhytotherapypt
dc.subject.meshMedicine, Traditionalpt
dc.subject.meshPhytochemicalspt
dc.subject.meshPlant Extractspt
dc.subject.meshAnacardiaceaept
dc.titleSpondias sp: Shedding Light on Its Vast Pharmaceutical Potentialpt
dc.typearticle-
degois.publication.firstPage1862pt
degois.publication.issue4pt
degois.publication.titleMoleculespt
dc.peerreviewedyespt
dc.identifier.doi10.3390/molecules28041862pt
degois.publication.volume28pt
dc.date.embargo2023-02-16*
uc.date.periodoEmbargo0pt
item.cerifentitytypePublications-
item.languageiso639-1en-
item.fulltextCom Texto completo-
item.grantfulltextopen-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypearticle-
crisitem.author.orcid0000-0003-2710-6000-
Appears in Collections:FFUC- Artigos em Revistas Internacionais
Files in This Item:
Show simple item record

Page view(s)

20
checked on May 22, 2024

Download(s)

12
checked on May 22, 2024

Google ScholarTM

Check

Altmetric

Altmetric


This item is licensed under a Creative Commons License Creative Commons